CN101849993A - Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry - Google Patents

Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry Download PDF

Info

Publication number
CN101849993A
CN101849993A CN201010198882A CN201010198882A CN101849993A CN 101849993 A CN101849993 A CN 101849993A CN 201010198882 A CN201010198882 A CN 201010198882A CN 201010198882 A CN201010198882 A CN 201010198882A CN 101849993 A CN101849993 A CN 101849993A
Authority
CN
China
Prior art keywords
parts
enteritis
sustained release
chinese medicine
slow releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201010198882A
Other languages
Chinese (zh)
Other versions
CN101849993B (en
Inventor
王洪杰
黄健
刘志辉
苏永鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shengshi Jialian (Tianjin) Biotechnology Co., Ltd.
Original Assignee
SRICK (TIANJIN) BIO-TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRICK (TIANJIN) BIO-TECHNOLOGY Co Ltd filed Critical SRICK (TIANJIN) BIO-TECHNOLOGY Co Ltd
Priority to CN2010101988829A priority Critical patent/CN101849993B/en
Publication of CN101849993A publication Critical patent/CN101849993A/en
Application granted granted Critical
Publication of CN101849993B publication Critical patent/CN101849993B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry, which comprise the following raw materials in part by weight: 3 to 8 parts of baical skullcap root extract, 10 to 20 parts of weeping forsythia extract, 0.2 to 0.5 part of toad venom, 3 to 8 parts of extractum glycyrrhizae, 1 to 3 parts of dahurian rhododendron leaf oil, 25 to 45 parts of hydroxypropyl methylcellulose and 10 to 20 parts of corn starch. The components of the Chinese medicinal sustained release tablets are scientifically compatible according to the GMP standard of veterinary medicaments on the basis of the theories of Chinese medicaments and sustained release preparations, semiquantitative detection is performed on active ingredients in main components by utilizing the modern scientific and technological means, and the Chinese medicinal sustained release tablets are developed by adopting the modern detection means and modern pharmaceutical equipment, and have the advantages of good curative effect, no medicament residues, high content, safety and reliability. The Chinese medicinal sustained release tablets have the definite curative effect through clinical verification, and are green veterinary medicaments which have no public hazards and medicament residues.

Description

A kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis
Technical field
The invention belongs to the herbal medicine formulation art, especially a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis.
Background technology
Respiratory system disease has become the problem that China many large-scale cultivations field and rural culture rich and influential family extremely pay close attention to; after poultry infect respiratory tract disease; the body performance descends; benefit reduces; and become the source of infection of other healthy poultry; and be to perplex numerous raisers' a difficult problem at the problem of the Drug therapy of livestock and birds respiratory disease, the main at present antibiotic therapy of using, but antibiotic drug residue has a strong impact on the healthy of people. always
At present the Chinese medicine veterinary drug of China also is in compatibility of drugs and lacks that systematic study, product forms are coarse, the low-level state of unstable product quality, and this situation is unfavorable for the sustainable development of China's poultry industry very much.Chinese medicine has that content is lower, and the drug disposition rate of release is uncontrollable, discharges the toxic and side effects of too fast easy enhancing medicine, and thing absorption difference effect is also poor.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, a kind of good effect, no drug residue, content height, safe and reliable treatment animal dysentery, the Chinese medicine slow releasing tablet of enteritis are provided.
The present invention realizes that the technical scheme of purpose is as follows:
A kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis comprises following raw material and each raw materials in part by weight:
3~8 parts of Radix Scutellariae extracts: Fructus Forsythiae extract 10-20 part; Venenum Bufonis: 0.2-0.5 part; Radix Glycyrrhizae extractum 3-8 part: Oleum Rhododendri Daurici 1-3 part; Hypromellose: 25-45 part; Corn starch: 10-20 part.
And, described Radix Scutellariae extract dry product meter, content of baicalin is no less than 85.0%, Fructus Forsythiae extract dry product meter, phillyrin content is no less than 0.50%, Radix Glycyrrhizae extractum dry product meter, glycyrrhizic acid content is no less than 20.0%.
And, also comprising the filling adjuvant, the weight fraction of interpolation is 20-30 part.
And the optimum weight umber of each raw material is as follows:
5 parts of Radix Scutellariae extracts: 15 parts of Fructus Forsythiae extracts; 0.3 part of Venenum Bufonis; 5 parts of Radix Glycyrrhizae extractum: 2 parts of Oleum Rhododendri Dauricis; 35 parts of hypromelloses; 15 parts of corn starchs; Fill 25 parts of adjuvants.
And be: described filling adjuvant comprises one of dextrin, sucrose or two or more mixture.
And the step of preparation is as follows:
(1) takes by weighing Radix Scutellariae extract, Fructus Forsythiae extract, Radix Glycyrrhizae extractum, Venenum Bufonis, Oleum Rhododendri Daurici elder generation slot-in type mixer mix homogeneously by weight;
(2) hypromellose, corn starch, filling adjuvant slot-in type mixer are continued to mix with said mixture, make soft material, granulate drying;
(3) above-mentioned dried particles and magnesium stearate are gone into three-dimensional mixer and mix, tabletting, packing.
Advantage of the present invention and beneficial effect are:
1, Chinese medicine slow releasing tablet of the present invention is according to tcm theory and slow releasing preparation theory, according to veterinary drug GMP standard, the science compatibility, and the utilization modern means of science and technology are carried out half-quantitative detection to the effective ingredient of key component, adopt a kind of good effect that modern detection means and modern pharmaceutical equipment develop, no drug residue, content height, safe and reliable Chinese medicine slow releasing tablet, through the clinical verification determined curative effect, be a kind of green veterinary drug of nuisanceless no drug residue.
2, the Chinese medicine slow releasing tablet of the present invention's preparation is pure Chinese medicine preparation, avoided the teratogenesis defective that disables of chemicals, add corn starch etc. simultaneously and play the slow releasing function composition, the slow release of medicine has improved the half-life of medicine, reduces medicining times, improve the ill domestic animal compliance, make haemoconcentration steady, avoid peak valley phenomenon, help reducing the toxic and side effects of medicine, reduce the accumulated dose of medication, to realize reaching maximum drug effect with minimum dose.
3, the Chinese medicine slow releasing tablet of the present invention's preparation is short according to the birds reproductive tract, can not digest the special physiological structure of wood fibre, pass through oral administration for ill poultry, medicine slowly discharges in vivo, directly, long-acting is in the affected part, having improved bioavailability, reduced the personnel's that culture labor intensity, is the desirable Chinese medicine preparation of current treatment livestock and birds respiratory disease.
The specific embodiment
The invention will be further described below by specific embodiment, and following examples are descriptive, is not determinate, can not limit protection scope of the present invention with this.
Embodiment 1:
A kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis, each raw material and parts by weight thereof are respectively:
5 parts of Radix Scutellariae extracts (the dry product meter contains baicalin and is no less than 85.0%);
15 parts of Fructus Forsythiae extracts (the dry product meter contains phillyrin and is no less than 0.50%);
5 parts of Radix Glycyrrhizae extractum (the dry product meter contains glycyrrhizic acid and is no less than 20.0%);
0.3 part of Venenum Bufonis; 2 parts of Oleum Rhododendri Dauricis; 35 parts of hypromelloses;
15 parts of corn starchs; 0.5 part of magnesium stearate; 18 parts in dextrin;
4.2 parts of sucrose.
Wherein Radix Scutellariae extract, Fructus Forsythiae extract, Radix Glycyrrhizae extractum are the extract after the water steaming and decocting, and the concentration of active substance need meet the demands in the extract, in the bracket of corresponding composition back.Dextrin and sucrose are filled adjuvant and also comprise the other materials of using as adjuvant in the medicines of being everlasting, as starch, maltose, other spice and sweeting agent etc. for filling adjuvant.
Preparation method is as follows:
(1) takes by weighing Radix Scutellariae extract, Fructus Forsythiae extract, Radix Glycyrrhizae extractum, Venenum Bufonis, Oleum Rhododendri Daurici adding trough type mixing machine mix homogeneously by weight ratio;
(2) hypromellose, corn starch are continued to mix with other adjuvant slot-in type mixers and said mixture, make soft material, granulate drying;
(3) above-mentioned dried particles and magnesium stearate are gone into three-dimensional mixer and mix, tabletting, packing, the percentage by weight that wherein adds magnesium stearate is 0.5%.
Embodiment 2
Radix Scutellariae extract (the dry product meter contains baicalin and is no less than 85.0%): 8 parts:
Fructus Forsythiae extract (the dry product meter contains phillyrin and is no less than 0.50%): 20 parts;
5 parts of Radix Glycyrrhizae extractum (the dry product meter contains glycyrrhizic acid and is no less than 20.0%):
0.5 part of Venenum Bufonis; 3 parts of Oleum Rhododendri Dauricis; Hypromellose: 45 parts;
20 parts of corn starchs; Other fill 30 parts of adjuvants;
Preparation method is with embodiment 1.
Embodiment 3
3 parts of Radix Scutellariae extracts (the dry product meter contains baicalin and is no less than 85.0%):
10 parts of Fructus Forsythiae extracts (the dry product meter contains phillyrin and is no less than 0.50%);
3 parts of Radix Glycyrrhizae extractum (the dry product meter contains glycyrrhizic acid and is no less than 20.0%):
0.2 part of Venenum Bufonis; 1 part of Oleum Rhododendri Daurici; 25 parts of hypromelloses;
10 parts of corn starchs; Fill 20 parts of adjuvants.
Preparation method is with embodiment 1.
Below be the assay of above-mentioned raw materials main component:
Radix Scutellariae extract: contain baicalin (C according to high effective liquid chromatography for measuring according to " Chinese veterinary drug allusion quotation " version in 2005 21H 18O 11) must not be less than 4.0%.
Fructus Forsythiae extract: contain phillyrin (C according to high effective liquid chromatography for measuring according to " Chinese veterinary drug allusion quotation " version in 2005 42H 62O 16) must not be less than 0.075%.
Radix Glycyrrhizae extractum: contain glycyrrhizic acid (C according to high effective liquid chromatography for measuring according to " Chinese veterinary drug allusion quotation " version in 2005 29H 36O 15) must not be less than 1%.
The pharmacology of each raw material of the present invention is:
Radix Scutellariae extract: have heat clearing and damp drying, eliminating fire and detoxication; The cough due to lung-heat, the damp and hot effect of gastrointestinal;
Fructus Forsythiae extract: have heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; The epidemic febrile disease heating, the yellow poisoning effect of skin ulcer;
Venenum Bufonis: have laryngopharynx swelling and pain, the yellow furunculosis effect of skin ulcer;
Oleum Rhododendri Daurici: have cough-relieving, an effect of eliminating the phlegm;
Radix Glycyrrhizae extract: have expelling phlegm for arresting cough and middle emergency, detoxifcation, coordinating the actions of various ingredients in a prescription, cushion toxicity, strong effect.Hypromellose: have effects such as emulsifying, thickening, suspending, adhesion-promoting, bonding, gelling and film forming;
Corn starch: have effects such as slow releasing agent, filler, adhesive.

Claims (6)

1. Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis is characterized in that: comprise following raw material and each raw materials in part by weight:
3~8 parts of Radix Scutellariae extracts: Fructus Forsythiae extract 10-20 part; Venenum Bufonis: 0.2-0.5 part; Radix Glycyrrhizae extractum 3-8 part: Oleum Rhododendri Daurici 1-3 part; Hypromellose: 25-45 part; Corn starch: 10-20 part.
2. a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis according to claim 1, it is characterized in that: described Radix Scutellariae extract dry product meter, content of baicalin is no less than 85.0%, Fructus Forsythiae extract dry product meter, phillyrin content is no less than 0.50%, Radix Glycyrrhizae extractum dry product meter, glycyrrhizic acid content is no less than 20.0%.
3. a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis according to claim 1 is characterized in that: also comprise the filling adjuvant, the weight fraction of interpolation is 20-30 part.
4. a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis according to claim 3, it is characterized in that: the optimum weight umber of each raw material is as follows:
5 parts of Radix Scutellariae extracts: 15 parts of Fructus Forsythiae extracts; 0.3 part of Venenum Bufonis; 5 parts of Radix Glycyrrhizae extractum: 2 parts of Oleum Rhododendri Dauricis; 35 parts of hypromelloses; 15 parts of corn starchs; Fill 25 parts of adjuvants.
5. according to claim 3 or 4 described a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis, it is characterized in that: described filling adjuvant comprises one of dextrin, sucrose or two or more mixture.
6. a kind of Chinese medicine slow releasing tablet for the treatment of animal dysentery, enteritis according to claim 3, it is characterized in that: the step of preparation is as follows:
(1) takes by weighing Radix Scutellariae extract, Fructus Forsythiae extract, Radix Glycyrrhizae extractum, Venenum Bufonis, Oleum Rhododendri Daurici elder generation slot-in type mixer mix homogeneously by weight;
(2) hypromellose, corn starch, filling adjuvant slot-in type mixer are continued to mix with said mixture, make soft material, granulate drying;
(3) above-mentioned dried particles and magnesium stearate are gone into three-dimensional mixer and mix, tabletting, packing.
CN2010101988829A 2010-06-11 2010-06-11 Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry Expired - Fee Related CN101849993B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101988829A CN101849993B (en) 2010-06-11 2010-06-11 Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101988829A CN101849993B (en) 2010-06-11 2010-06-11 Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry

Publications (2)

Publication Number Publication Date
CN101849993A true CN101849993A (en) 2010-10-06
CN101849993B CN101849993B (en) 2013-05-22

Family

ID=42801782

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101988829A Expired - Fee Related CN101849993B (en) 2010-06-11 2010-06-11 Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry

Country Status (1)

Country Link
CN (1) CN101849993B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111632094A (en) * 2019-09-20 2020-09-08 中国农业大学 Application of composition in preventing or treating diseases caused by escherichia coli of broiler chicken

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1359689A (en) * 2000-12-18 2002-07-24 藏春芝 Medicine for treating dysentery of animals and fowls and its preparing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1359689A (en) * 2000-12-18 2002-07-24 藏春芝 Medicine for treating dysentery of animals and fowls and its preparing process

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111632094A (en) * 2019-09-20 2020-09-08 中国农业大学 Application of composition in preventing or treating diseases caused by escherichia coli of broiler chicken
CN111632094B (en) * 2019-09-20 2021-09-21 中国农业大学 Application of composition in preventing or treating diseases caused by escherichia coli of broiler chicken

Also Published As

Publication number Publication date
CN101849993B (en) 2013-05-22

Similar Documents

Publication Publication Date Title
Yan et al. Discovery of anti-2019-nCoV agents from Chinese patent drugs via docking screening
CN111110824A (en) Medicinal composition for strengthening body resistance and rescuing lung and application thereof
CN100389816C (en) Tibetan medicine formulation for treating hyperlipemia, and its preparing method
CN102068494B (en) Health-care capsules with treatment effect on chemical liver injury and preparation method thereof
CN102283895A (en) Preparation technology and production method of integrated novel Lingguizhugan decoction dosage form
CN100542575C (en) A kind of medicine for the treatment of rhinitis and preparation method thereof
CN100387277C (en) Preparation method of notoginseng-containing tablet for treating traumatic injury
CN101543480A (en) Tablets
CN102697935A (en) Chinese medicinal particle for preventing and treating duck plague and preparation method thereof
CN101849993B (en) Chinese medicinal sustained release tablets for treating dysentery and enteritis of livestock and poultry
CN1686423A (en) Medicinal composition containing scutellaria glucoside and bupleurum and its preparation method
CN101933919A (en) Application of brown cyanidin
CN104352427A (en) Pharmaceutical composition containing andrographolide and use of pharmaceutical composition
CN100363043C (en) Chinese traditional medicine composition for treating rheumatic or rheumatoid disease and preparation method thereof
CN101919910A (en) Method for preparing traditional Chinese medicine sustained release tablets for treating livestock dysentery and enteritidis
CN103054952A (en) Medicine for treating periodontitis and preparation method thereof
CN103638336B (en) Full rhizoma gastrodiae tablet
CN1220513C (en) Proprietury Chinese medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method
CN1839956A (en) Pharmaceutical composition containing curcumin and its formulation
CN101890057A (en) Herba Pteridis Multifidae preparation that treatment gastrointestinal tract, urinary tract infection and the heart, cerebrovascular disease are used and preparation method thereof
CN103919845A (en) Pharmaceutical composition for improving anoxia endurance and preparation method and application thereof
CN102631421A (en) Traditional Chinese medicine for treating senile dementia
CN102058668A (en) Traditional Chinese medicinal preparation for treating primary thrombocytopenia
CN102526647A (en) Preparation technology and production method of novel dual-purpose decoction integrated dosage form
CN105395684A (en) Traditional Chinese compound for relieving exterior syndromes, dispelling cold, eliminating dampness and relieving pain and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190115

Address after: No. 38 Huafeng Road, Beichen Economic and Technological Development Zone, Beichen District, Tianjin 300400

Patentee after: Shengshi Jialian (Tianjin) Biotechnology Co., Ltd.

Address before: No. 27 Samsung Road, Zhongbei Industrial Park, Xiqing District, Tianjin 300380

Patentee before: Srick (Tianjin) Bio-Technology Co., Ltd.

Effective date of registration: 20190115

Address after: No. 38 Huafeng Road, Beichen Economic and Technological Development Zone, Beichen District, Tianjin 300400

Patentee after: Shengshi Jialian (Tianjin) Biotechnology Co., Ltd.

Address before: No. 27 Samsung Road, Zhongbei Industrial Park, Xiqing District, Tianjin 300380

Patentee before: Srick (Tianjin) Bio-Technology Co., Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130522

Termination date: 20190611

CF01 Termination of patent right due to non-payment of annual fee